TABLE 3.
Self-reported chronic conditions as well as medication use for subjects enrolled in the study.
| Baseline Assessment | All n = 52 | Pre-F n = 30 | Pre-NF n = 22 | p-level |
| Number of Chronic Conditions (n) | 8.2 (3.3) | 8.6 (3.2) | 7.8 (3.4) | 0.39 |
| Peripheral Neuropathy (n) | 52(100%) | 30(100%) | 22(100%) | n/a |
| Numbness in Feet (n) | 49(94%) | 30(100%) | 19(86%) | 0.05 |
| Neuropathic Pain in Feet (n) | 38(73%) | 22(73%) | 16(73%) | 0.96 |
| Hypertension (n) | 33(63%) | 19(63%) | 14(64%) | 0.98 |
| Back Pain (n) | 26(50%) | 16(53%) | 10(45%) | 0.57 |
| Arthritis (n) | 24(46%) | 15(50%) | 9(41%) | 0.52 |
| Knee Dysfunction (n) | 23(44%) | 14(47%) | 9(41%) | 0.68 |
| Diabetes Diagnosis (n) | 19(37%) | 9(30%) | 10(45%) | 0.25 |
| Inner Ear Problems (n) | 17(33%) | 9(30%) | 8(36%) | 0.63 |
| Heart Disease (n) | 16(31%) | 10(33%) | 6(27%) | 0.64 |
| Neck Pain (n) | 16(31%) | 9(30%) | 7(32%) | 0.89 |
| Cancer (n) | 16(31%) | 13(43%) | 3(14%) | 0.03 |
| Lung Disease (n) | 10(19%) | 7(23%) | 3(14%) | 0.38 |
| Stroke (n) | 9(17%) | 4(13%) | 5(23%) | 0.38 |
| Osteoporosis (n) | 10(19%) | 7(23%) | 3(14%) | 0.38 |
| Seizures (n) | 5(10%) | 3(10%) | 2(9%) | 0.91 |
| Ankle Dysfunction (n) | 5(10%) | 4(13%) | 1(5%) | 0.29 |
| TMJ/Jaw Pain (n) | 5(10%) | 2(7%) | 3(14%) | 0.40 |
| Fainting (n) | 5(10%) | 2(7%) | 3(14%) | 0.40 |
| Migraines (n) | 4(8%) | 2(7%) | 2(9%) | 0.75 |
| Meningitis (n) | 0 | 0 | 0 | n/a |
| Other Conditions (n) | 14(27%) | 11(37%) | 3(14%) | 0.06 |
| Difficulty Walking/balance (n) | 52(100%) | 30(100%) | 22(100%) | n/a |
| Mean (SD) Median | Mean (SD) | Mean (SD) | p-level | |
| Prescription Medications (n) | 8 | 8.5 | 7 | 0.50 |
| Non-Prescription Medications (n) | 1 | 1 | 1 | n/a |
| Medications Associated with Falls (n) | 3 | 3 | 3 | n/a |
Column p-level shows significance level for comparison between the Pre-F and Pre-NF groups. In bold if p < 0.05.